Page last updated: 2024-10-24

cefuroxime and Osteoarthritis, Hip

cefuroxime has been researched along with Osteoarthritis, Hip in 1 studies

Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.

Osteoarthritis, Hip: Noninflammatory degenerative disease of the hip joint which usually appears in late middle or old age. It is characterized by growth or maturational disturbances in the femoral neck and head, as well as acetabular dysplasia. A dominant symptom is pain on weight-bearing or motion.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, A1
Yates, P1
Lovering, A1
Bannister, GC1
Spencer, RF1

Other Studies

1 other study available for cefuroxime and Osteoarthritis, Hip

ArticleYear
The effect of surgical approach on blood flow to the femoral head during resurfacing.
    The Journal of bone and joint surgery. British volume, 2007, Volume: 89, Issue:1

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Cefuroxime; Female; Femur

2007